ProPath's Women's Services include the primary screening services for gynecologic and non-gynecologic samples as well as professional pathology services for interpretation of potential abnormalities detected in the primary examination process.

Cytology is a highly regulated medical field requiring skilled cytotechnologists to assess the thousands of cells on each slide and render accurate interpretations of cellular changes. Our laboratory is inspected and accredited by the Laboratory Accreditation Program of the College of American Pathologists (CAP).

A comprehensive quality control and quality improvement program is strictly followed. All pathologists and cytotechnologists engaged in the interpretation of cellular abnormalities at ProPath participate in the various proficiency testing programs of the CAP.

• Baer A., Kiviat, N, Kulasingam, S., Mao, C., Kuypers, J. and Koutsky, L. “Liquid-based Papanicolaou Smears Without a Transformation Zone Component: Should Clinicians Worry?” The American College of Obstetricians and Gynecologists Transformation Zone Component 99:6 (June 2002): 1053-1059
• Davey, D., Austin, M., Birdsong, G., Buck, H., Cox, T., Darragh, T., Elgert, P., Hanson, V., Henry, M., Waldman, J. “ASCCP Patient Management Guidelines: Pap Test Specimen Adequacy and Quality Indicators,” American Society for Colposcopy and Cervical Pathology Journal of Lower Genital Tract Disease 6:3 (2002): 195-199
• Solomon, D., Davey, D., Kurman, R., Moriarty, A., O’Connor, D., Prey, M., Raab, S., Sherman, M., Wilbur, D., Wright, T., Young, N. “The 2001 Bethesda System Terminology for Reporting Results of Cervical Cytology,” Journal of the American Medical Association 287:16 (April 2002): 2114-2119